Literature DB >> 17206392

Transcatheter embolization of a renal artery aneurysm using ethylene vinyl alcohol copolymer.

Riitta Rautio1, Arto Haapanen.   

Abstract

Our aim was to treat a clinically silent renal artery aneurysm. The patient was a 76-year-old man with elevated prostate-specific antigen and prostate biopsies with a grade II-III adenocarcinoma who was incidentally found to have an aneurysm in his right renal artery. We performed a successful transcatheter embolization of the aneurysm using ethylene vinyl alcohol copolymer (Onyx). To avoid migration of the liquid material into the parent artery, a balloon was inflated in the orifice of the neck of the aneurysm while the liquid was injected. Five-month follow-up computed tomography (CT) imaging confirmed total occlusion of the aneurysm.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17206392     DOI: 10.1007/s00270-005-0238-2

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  4 in total

1.  Ruptured renal artery aneurysm: coil packing with GDCs.

Authors:  Misako Takeuchi; Manabu Nakata; Akira Kawai; Kazumi Suzuki; Tatsuo Morita; Hideharu Sugimoto
Journal:  Jpn J Radiol       Date:  2012-02-29       Impact factor: 2.374

Review 2.  [Embolotherapy: principles and indications].

Authors:  P Landwehr; S Arnold; G Voshage; P Reimer
Journal:  Radiologe       Date:  2008-01       Impact factor: 0.635

Review 3.  Vascular anomalies: A pictorial review of nomenclature, diagnosis and treatment.

Authors:  John L Nosher; Philip G Murillo; Mark Liszewski; Vyacheslav Gendel; Christopher E Gribbin
Journal:  World J Radiol       Date:  2014-09-28

4.  Case series: Transplantation of kidneys from donors with renal artery aneurysm.

Authors:  Mahmoud Alameddine; Zhobin Moghadamyeghaneh; Giselle Guerra; Mahmoud Morsi; Mohammed Osman; V J Chia; George W Burke; Linda Chen; Rodrigo Vianna; Ian Zheng; Javier González; Gaetano Ciancio
Journal:  Can Urol Assoc J       Date:  2017-07-11       Impact factor: 1.862

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.